These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 10586488

  • 1. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
    Wissel J, Müller J, Heinen F, Mall V, Sojer M, Ebersbach G, Poewe W.
    Wien Klin Wochenschr; 1999 Oct 29; 111(20):837-42. PubMed ID: 10586488
    [Abstract] [Full Text] [Related]

  • 2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 Oct 29; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J, Bogucki A, Reclawowicz D.
    Neurol Sci; 2005 Apr 29; 26(1):32-9. PubMed ID: 15877185
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment.
    Wissel J, Heinen F, Schenkel A, Doll B, Ebersbach G, Müller J, Poewe W.
    Neuropediatrics; 1999 Jun 29; 30(3):120-4. PubMed ID: 10480205
    [Abstract] [Full Text] [Related]

  • 5. [Botulinum toxin as a treatment for infantile cerebral palsy].
    Pascual-Pascual SI, Sánchez de Muniain P, Roche MC, Pascual-Castroviejo I.
    Rev Neurol; 1997 Sep 29; 25(145):1369-75. PubMed ID: 9377292
    [Abstract] [Full Text] [Related]

  • 6. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H, Kotamäki A, Koivikko M, Autti-Rämö I.
    Pediatr Rehabil; 2006 Sep 29; 9(3):247-58. PubMed ID: 17050402
    [Abstract] [Full Text] [Related]

  • 7. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F, Sandrini G, Moglia A, Nappi G, Pacchetti C.
    Neurol Sci; 2005 Apr 29; 26(1):26-31. PubMed ID: 15877184
    [Abstract] [Full Text] [Related]

  • 8. Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
    Suputtitada A, Phanthumchinda K, Locharernkul C, Suwanwela NC.
    J Med Assoc Thai; 2004 Oct 29; 87(10):1205-11. PubMed ID: 15560699
    [Abstract] [Full Text] [Related]

  • 9. Interventional neuropediatrics: treatment of dystonic and spastic muscular hyperactivity with botulinum toxin A.
    Heinen F, Wissel J, Philipsen A, Mall V, Leititis JU, Schenkel A, Stücker R, Korinthenberg R.
    Neuropediatrics; 1997 Dec 29; 28(6):307-13. PubMed ID: 9453027
    [Abstract] [Full Text] [Related]

  • 10. [Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology].
    Sławek J, Madaliński MH, Maciag-Tymecka I, Duzyński W.
    Pol Merkur Lekarski; 2005 Mar 29; 18(105):298-302. PubMed ID: 15997637
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of botulinum toxin type A for chronic cough: a neuropathic model.
    Chu MW, Lieser JD, Sinacori JT.
    Arch Otolaryngol Head Neck Surg; 2010 May 29; 136(5):447-52. PubMed ID: 20479373
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
    Grosse J, Kramer G, Jakse G.
    BJU Int; 2009 Sep 29; 104(5):651-6. PubMed ID: 19281462
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Management of spasticity associated pain with botulinum toxin A.
    Wissel J, Müller J, Dressnandt J, Heinen F, Naumann M, Topka H, Poewe W.
    J Pain Symptom Manage; 2000 Jul 29; 20(1):44-9. PubMed ID: 10946168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.